Drug for treating circulatory insufficiency
    3.
    发明申请
    Drug for treating circulatory insufficiency 审中-公开
    用于治疗循环功能不全的药物

    公开(公告)号:US20110021621A1

    公开(公告)日:2011-01-27

    申请号:US12923589

    申请日:2010-09-29

    CPC分类号: C07D311/56 A61K31/37

    摘要: The present invention relate to a drug for treating circulatory insufficiency containing a benzopyran derivative represented by the following general formula (I): and/or a physiologically acceptable salt thereof as an active ingredient, wherein R1 is an alkyl group having 1 to 10 carbon atoms, or an alkenyl group having 2 to 10 carbon atoms; and any one of R2, R3, R4 and R5 is a hydroxyl group, an alkoxy group, an alkenyloxy group, an alkoxy group substituted with a hydroxyl group, or an alkoxy group substituted with a carboxy group, and the others are hydrogen atoms.

    摘要翻译: 本发明涉及含有下列通式(I)表示的苯并吡喃衍生物的循环功能不全药物:和/或其生理学上可接受的盐作为有效成分,其中R1为碳原子数1〜10的烷基 ,或具有2〜10个碳原子的烯基; R 2,R 3,R 4和R 5中的任一个是羟基,烷氧基,烯氧基,被羟基取代的烷氧基或被羧基取代的烷氧基,其它是氢原子。

    Drug for Treating Circulatory Insufficiency
    4.
    发明申请
    Drug for Treating Circulatory Insufficiency 审中-公开
    药物治疗循环不足

    公开(公告)号:US20090099256A1

    公开(公告)日:2009-04-16

    申请号:US12084052

    申请日:2006-10-23

    CPC分类号: C07D311/56 A61K31/37

    摘要: The present invention relate to a drug for treating circulatory insufficiency containing a benzopyran derivative represented by the following general formula (I): and/or a physiologically acceptable salt thereof as an active ingredient, wherein R1 is an alkyl group having 1 to 10 carbon atoms, or an alkenyl group having 2 to 10 carbon atoms; and any one of R2, R3, R4 and R5 is a hydroxyl group, an alkoxy group, an alkenyloxy group, an alkoxy group substituted with a hydroxyl group, or an alkoxy group substituted with a carboxy group, and the others are hydrogen atoms.

    摘要翻译: 本发明涉及含有下列通式(I)表示的苯并吡喃衍生物的循环功能不全药物:和/或其生理学上可接受的盐作为有效成分,其中R1为碳原子数1〜10的烷基 ,或具有2〜10个碳原子的烯基; R 2,R 3,R 4和R 5中的任一个是羟基,烷氧基,烯氧基,被羟基取代的烷氧基或被羧基取代的烷氧基,其它是氢原子。